FDAnews
www.fdanews.com/articles/81833-ceptor-corporation-to-receive-1-5-million-from-jcr-pharmaceuticals-upon-ind-filing

CEPTOR CORPORATION TO RECEIVE $1.5 MILLION FROM JCR PHARMACEUTICALS UPON IND FILING

October 21, 2005

CepTor Corporation (OTCBB:CEPO), a development-stage biopharmaceutical company focusing on cell targeted therapeutic products for neuromuscular and neurodegenerative diseases, today announced that it will receive a $1.5 million milestone payment from JCR Pharmaceuticals of Japan upon filing an Investigational New Drug (IND) application for Myodur (C-101) in muscular dystrophy. The payment will include $1 million in equity at the then current market price and $500,000 in cash.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051020005467&newsLang=en)